Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Sort descending Organization
Nov
29
2017
November 29, 2017 Update: gTLD Sunrise Periods Now Open Sterne, Kessler, Goldstein & Fox P.L.L.C.
Nov
2
2013
Novozymes Looses “Possession” Of Its Enzyme Re: Patent Litigation Schwegman, Lundberg & Woessner, P.A.
Jan
29
2016
NRT Tech. Corp. et al. v. Everi Payments: Denying Institution of CBM Asserting Patent Ineligibility and Prior Art Under Section 102(e) CBM2015-00167 Faegre Drinker
Sep
22
2020
NSF Will Invest $84 Million in National Nanotechnology Coordinated Infrastructure Bergeson & Campbell, P.C.
Sep
13
2011
NTP Patents Revisited McDermott Will & Emery
Aug
23
2012
Nuclear Regulator Announces Temporary Suspension of Licensing Decisions McDermott Will & Emery
Oct
27
2016
Nucleic Acids Remain Patentable in Australia K&L Gates
Jun
21
2012
Number of gTLD Applications Nearly Quadruples Expectations 7 Month Objection Period Opens Armstrong Teasdale
Apr
4
2018
Numerous Imports Targeted as U.S. -China Trade Tensions Escalate U.S. Proposes List of 1,300 Products Subject to Section 301 Tariffs; China Counters with Own List of U.S. Imports Covington & Burling LLP
Jul
18
2014
Nuvasive, Inc. v. Warsaw Orthopedic, Inc., Final Written Decision (FWD) Faegre Drinker
Nov
21
2019
Nuvo Pharms. v. Dr. Reddy’s Labs. – Catch 22 at the Federal Circuit? Schwegman, Lundberg & Woessner, P.A.
Nov
2
2015
Nvidia Corp. v. Samsung Electronics Co: Petitioner Required to Map Prior Art Claims to Provisional Application IPR2015-01315 Faegre Drinker
Aug
3
2022
NY Attorney Suspended for Filing Over 18,000 U.S. Trademark Applications for Chinese Agents Without Proper Review Schwegman, Lundberg & Woessner, P.A.
Oct
8
2021
NYC vs Robert Lopez for His Cannabis-Themed Marks Norris McLaughlin P.A.
Aug
14
2013
Obama Administration Disapproves International Trade Commission's (ITC) Exclusion Order on Apple Products McDermott Will & Emery
Nov
6
2015
Obama Administration Releases Much Anticipated Text of the Trans-Pacific Partnership Agreement Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jan
12
2011
Obama Artwork Copyright Case Dismissed Risk and Insurance Management Society, Inc. (RIMS)
Feb
8
2016
Obama Launches Cancer Moonshot Task Force – But Where’s Patent Power? Schwegman, Lundberg & Woessner, P.A.
May
11
2016
Obama Signs Federal Trade Secret Act Jones Walker LLP
May
12
2016
Obama Signs Federal Trade Secrets Bill Into Law Squire Patton Boggs (US) LLP
Jun
28
2014
Objective Baselessness and Subjective Bad Faith for Exceptional Case Determination Are Still Applicable Even After Octane Fitness Bianco v. Globus Medical, Inc. McDermott Will & Emery
Aug
3
2014
Objective Evidence Based on Unclaimed Species Insufficient Nexus McDermott Will & Emery
Aug
31
2013
Objective Indicia of Non-Obviousness Must Be Considered Before Concluding Patent Claims Are Obvious McDermott Will & Emery
Aug
13
2021
Objective Indicia: Nexus Analysis May Require Evaluation of Claims as a “Unique Combination” Finnegan
Jun
3
2015
Obligation to Enforce Arbitration under FAA Policy Trumps Motion to Prevent Enforcement of “Clearly Void” Non-Competition Agreement Womble Bond Dickinson (US) LLP
Apr
4
2020
Obtaining Signatures On Patent And Trademark Documents, Inventor Assignments While Sheltering In Place Barnes & Thornburg LLP
Mar
24
2016
Obtaining Stays in Parallel Litigation re: Intellectual Property Michael Best & Friedrich LLP
Aug
1
2013
Obvious to Try and the Prima Facie Obviousness Patent Infringement Case Novo Nordisk A/S v. Caraco Pharmaceutical Labs. Ltd. McDermott Will & Emery
Dec
16
2021
Obvious to Try Requires Reasonable Expectation of Success Tethered to Claimed Invention McDermott Will & Emery
Jun
15
2023
Obviously Prima Facie Case Overcome by Secondary Considerations McDermott Will & Emery
Oct
17
2011
Obviousness = Equivalence? Saint-Gobain v. Siemens Schwegman, Lundberg & Woessner, P.A.
Aug
29
2018
Obviousness Cannot Be Predicated on What Is Unknown McDermott Will & Emery
Aug
30
2017
Obviousness Does Not Require Absolute Predictability: Soft Gel Tech v. Jarrow Formulas McDermott Will & Emery
Oct
27
2016
Obviousness Inquiry Allows Flexibility in Considering Teachings of Prior Art McDermott Will & Emery
Jan
4
2015
Obviousness Must Be Supported by Analysis and Factual Findings McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins